Abstract
WNT/β-catenin signaling is critical to the development of many cancer types. A paper by Mo and colleagues in a recent issue of Cell shows that autocrine CXCL12/CXCR4 chemokine signaling activates β-catenin signaling in a rare peripheral nerve sarcoma. Together with the availability of small molecules targeting CXCR4, this finding suggests new avenues for cancer therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 269-271 |
Number of pages | 3 |
Journal | Cancer Cell |
Volume | 23 |
Issue number | 3 |
DOIs | |
State | Published - Mar 18 2013 |